Antibacterial activity of traditional medicinal plants used by Haudenosaunee peoples of New York State
© Frey and Meyers; licensee BioMed Central Ltd. 2010
Received: 9 July 2010
Accepted: 6 November 2010
Published: 6 November 2010
The evolution and spread of antibiotic resistance, as well as the evolution of new strains of disease causing agents, is of great concern to the global health community. Our ability to effectively treat disease is dependent on the development of new pharmaceuticals, and one potential source of novel drugs is traditional medicine. This study explores the antibacterial properties of plants used in Haudenosaunee traditional medicine. We tested the hypothesis that extracts from Haudenosaunee medicinal plants used to treat symptoms often caused by bacterial infection would show antibacterial properties in laboratory assays, and that these extracts would be more effective against moderately virulent bacteria than less virulent bacteria.
After identification and harvesting, a total of 57 different aqueous extractions were made from 15 plant species. Nine plant species were used in Haudenosaunee medicines and six plant species, of which three are native to the region and three are introduced, were not used in traditional medicine. Antibacterial activity against mostly avirulent (Escherichia coli, Streptococcus lactis) and moderately virulent (Salmonella typhimurium, Staphylococcus aureus) microbes was inferred through replicate disc diffusion assays; and observed and statistically predicted MIC values were determined through replicate serial dilution assays.
Although there was not complete concordance between the traditional use of Haudenosaunee medicinal plants and antibacterial activity, our data support the hypothesis that the selection and use of these plants to treat disease was not random. In particular, four plant species exhibited antimicrobial properties as expected (Achillea millefolium, Ipomoea pandurata, Hieracium pilosella, and Solidago canadensis), with particularly strong effectiveness against S. typhimurium. In addition, extractions from two of the introduced species (Hesperis matronalis and Rosa multiflora) were effective against this pathogen.
Our data suggest that further screening of plants used in traditional Haudenosaunee medicine is warranted, and we put forward several species for further investigation of activity against S. typhimurium (A. millefolium, H. matronalis, I. pandurata, H. pilosella, R. multiflora, S. canadensis).
North American Native American peoples used approximately 2,600 species of vascular plants in traditional medicines [1, 2]. This figure represents roughly 10% of all vascular plant species in North America, and there is evidence that the choice of medicinal plants was non-random  and closely linked to phylogenetic relationships . This bias in selectivity may speak to the efficacy of traditional remedies in the context of shared evolutionary descent (i.e., therapeutic compounds conserved among closely related plant species) much in the same way that certain classes of molecules are conserved among families such as the Apocynaceae (cardioactive glycosides), Caprifoliaceae (cyanogenic glycosides), Papaveraceae (alkaloids), and Solonaceae (glycoalkaloids) .
In Upstate New York, the Haudenosaunee (Iroquois) peoples used approximately 450 plant species in traditional medicine [6, 7], which is similar in number to plant species used medicinally by neighboring First Nations Peoples in eastern Canada . A number of studies have demonstrated concordance between selectivity of plants among First Nations Peoples to treat specific symptoms and demonstrated antibacterial, antifungal, and antiviral activity in the laboratory [9–16]. In this study, we use similar approaches to provide the first investigation of the antibacterial properties of plants used in Haudenosaunee traditional medicine.
We selected 15 plants for our investigation and screened them against four bacterial species. Four plants are considered among the most powerful medicines in traditional Haudenosaunee culture (Achillea millefolium, Asclepias syriaca, Ipomoea pandurata, Malva neglecta), serving as panacea remedies for a diversity of physical and spiritual ailments [6, 7]. Five plants were used in Haudenosaunee medicines to treat a diversity of ailments (Cimicifuga racemosa, Hieracium pilosella, Lycopodium digitatum, Ranunculus acris, Solidago canadensis); although these were not considered among the approximately 150 most powerful medicines [6, 7], they were well represented in regional Native American medicines [1, 2]. In addition, we selected two native plant species (Arabis glabra, Silene virginica) and four introduced species (Hesperis matronalis, Myosotis scorpioides, Rosa multiflora, Silene latifolia) with no record of medicinal use among Haudenosaunee peoples [1, 2, 6, 7].
We chose to test these plants against four bacterial species that vary with respect to their disease modality and virulence (Escherichia coli, Salmonella typhimurium [Salmonella enterica subspecies enterica serovar Typhimurium], Staphylococcus aureus, Streptococcus [Lactococcus] lactis). Streptococcus lactis is a gram-positive species used extensively in the dairy industry and regarded as an avirulent opportunistic human pathogen [17–19]; similarly, E. coli is a gram-negative human enteric species that is generally avirulent but sometimes causes weakly virulent gastroenteritis and urinary tract infections . Salmonella typhimurium is a gram-negative pathogen that most commonly causes enterocolitis, and S. aureus is a gram-positive pathogen that most commonly causes abscess, food poisoning, and toxic shock syndrome; both are considered to be more virulent than S. lactis and E. coli.
Broadly, we hypothesized that we would find congruity between the use of particular plant species to treat specific symptoms by Haudenosaunee peoples and demonstrated antibacterial properties. Specifically, we hypothesized that plants used to treat symptoms possibly associated with bacterial pathogens (e.g., antipyretics, antidiarrheals, antiemetics, broad gastrointestinal treatments, dermatological ailments, etc.) would show more antibacterial activity than those plants used to treat other symptoms (e.g., analgesics, blood medicines, contraceptives, etc.). Additionally, we hypothesized that the greatest antibacterial effects would be observed in the more moderately virulent pathogens (S. typhimurium and S. aureus) compared to the less virulent pathogens (S. lactis and E. coli).
Plant collection and extract preparation
Plant species utilized in this study and Haudenosaunee medicinal properties.
Medicinal Propertiesa, b
"Powerful" Haudenosaunee medicinal plants c
Analgesic (LV, RT), Antidiarrheal (PL), Antiemetic (LV, ST), Antihelmintic (LV), Antipyretic (PL), Antirheumatic (PL), Blood (PL), Gastrointestinal (PL), Panacea drug (LV), Venereal Disease (PL)
Circulation (RT, PL), Dermatological (ST), Gastrointestinal (LV), Gynecological (PL)
Man of the Earth
Analgesic (RT, PL), Blood (RT, LV, ST), Cough (RT), Gastrointestinal (RT, PL), Liver (PL), Panacea (PL), Witchcraft (PL)
Analgesic (PL), Dermatological (PL), Gastrointestinal (PL), Orthopedic (PL)
Other Haudenosaunee medicinal plants
Antirheumatic (RT, PL), Blood (RT), Orthopedic (LV)
Anticonvulsive (PL), Diuretic (PL), Reproductive (PL)
Analgesic (PL), Antidiarrheal (RT), Blood (PL)
Analgesic (RT, FL), Emetic (RT, FL), Gastrointestinal (FL), Liver (FL), Sedative (RT)
Plants with no known medicinal use by Haudenosaunee d
Arabis glabra (N)
Myosotis scorpioides (N)
Silene virginica (N)
Hesperis matronalis (I)
Rosa multiflora (I)
Silene latifolia (I)
Preparations of inoculums of microorganisms
Extracts were screened against two gram-negative bacteria (Escherichia coli [Presque Isle No.336] and Salmonella typhimurium [Presque Isle No.381]) and two gram-positive bacteria (Staphylococcus aureus [Presque Isle No.4651] and Streptococcus lactis [Presque Isle No.525]). Escherichia coli and S. aureus were maintained on Liquid Broth (LB) slant cultures (Krackeler Scientific, Albany, NY USA), and S. typhimurium and S. lactis were maintained on Brain Heart Infusion (BHI) slant cultures (Krackeler Scientific, Albany, NY USA). All slant cultures were kept at 37°C. Twenty-four hours before screening with disc diffusion or 96-well plate assays, replicate liquid cultures were started by placing a loopful of bacteria from the slant cultures into 10 mL of appropriate sterile media (E. coli and S. aureus in LB; S. typhimurium and S. lactis in BHI) and grown at 37°C. Immediately prior to all experiments, the turbidity of each liquid culture for use in the assays was adjusted to 0.5 McFarland Units (approx. 1 × 108 CFU/mL) using sterile LB or BHI.
Disc diffusion assays
The sensitivity of different bacterial strains to the aqueous plant extracts was measured using a standard agar diffusion assay . Sterile 100 × 15 mm Petri plates containing bacto-agar (Krackeler Scientific, Albany, NY USA) and either LB or BHI were prepared prior to beginning the assays, and 100 μL of liquid bacterial culture was spread onto plates with the appropriate media using sterile technique (E. coli and S. aureus on LB; S. typhimurium and S. lactis on BHI). Immediately prior to their placement on the plates, 10 μL of extract (100 mg/mL) was pipetted onto a 6 mm sterile filter paper disc. Each plate contained four paper discs; two discs contained extracts, one disc served as a negative control (10 μL sterile water), and one disc served as a positive control (10 μL of 10 mg/mL ampicillin). Each extract was tested on three replicate plates, and the plates were inverted and incubated at 37°C for 24 hours before being digitally photographed. Images were uploaded to a computer and zones of inhibition were calculated using ImageJ http://rsb.info.nih.gov/ij/. For each image, the pixel-to-centimeter relationship was calculated using a standard reference contained in the image, and the area and diameter of the zone of inhibition was measured directly. All zones of inhibition were circular.
96-well plate assays
Sixteen of the extracts were selected for use in the 96-well plate assay because they caused substantial zones of inhibition on one or more of the bacteria tested. Serial dilutions of each of these extracts were prepared using sterile water to produce final concentrations of 100% (not diluted), 50%, 25%, 12.5%, 6.25%, and 3.125%. In terms of fresh material to solvent, these dilutions represent concentrations of 100 mg/mL, 50 mg/mL, 25 mg/mL, 12.5 mg/mL, 6.25 mg/mL, and 3.125 mg/mL, respectively. The procedures used in this assay were similar to those used in another study where an indicator solution changes from clear to red in proportion to the degree of bacterial activity . To start, the twelve-row by eight-column plate was visually divided into four sections of two columns each; one column was designated the "experimental" column and one was designated the "control". Each of these two-column sections was used to test a single extract as follows. Bacteria were prepared as described above (approx. 1 × 108 CFU/mL) to provide enough stock to fill all plates for all extracts tested (i.e., all of the tests involving a single bacteria species were performed on the same day). Then, 100 μL of liquid culture was placed into each cell of the experimental column along with 100 μL of each of the following solutions down the 8 rows: positive control (10 mg/mL ampicillin), negative control (sterile water), 100%, 50%, 25%, 12.5%, 6.25%, and 3.125% extract. The positive control cell (ampicillin) should have no bacterial activity and remain clear, whereas the negative control cell (water) should have bacterial activity and change to red, providing reference points to quantify the inhibitory effects of the extract dilutions. The control column only contained 100 μL of the positive control (ampicillin), negative control (water), and extraction dilution solutions (i.e., identical to the experimental column except no bacteria were present). Plates were prepared in triplicate such that each extract-bacteria combination was replicated across 96-well plates. Plates were covered and incubated at 37°C for 24 hours. After the 24-hour incubation, 40 μL of a 0.2 mg/mL p-iodonitrotetrazolium violet (INT) indicator solution was simultaneously added to every well and the plate was incubated at 37°C for an additional 30 minutes. The INT indicator solution changes from clear to red in the presence of bacterial activity and the degree of redness is a good measure of inhibitory effects . Following the 30-minute incubation, plates were digitally photographed.
In order to assess the inhibitory effects of each of the extracts, images were uploaded to a computer and ImageJ http://rsbweb.nih.gov/ij/ was used to calculate the mean gray value by converting each pixel within the well to grayscale and then summing the gray values of all the pixels in the well and then dividing by the total number of pixels. ImageJ uses a standard formula to perform this conversion: gray = 0.299 red + 0.587 green + 0.114 blue. Then, the mean gray value of the cell containing the extract alone was subtracted from the cell containing the extract and bacteria combination to remove the effects of extract coloration on gray value. This difference was divided by the negative control (water) gray value to determine the fraction of bacteria alive in the experimental cell relative to the cell containing only water, and for simplicity of interpretation this quotient was subtracted from 1 to convert the fractions into a "proportion killed" as opposed to a "proportion alive". Although it is possible to split out the red values independent of the green and blue values and perform a similar analysis, preliminary experiments with a series of controlled-dye solutions showed that converting to gray values explained more of the observed variation in color (Frey, unpublished data).
In the disc diffusion assays, the average size of the zone of inhibition (N = 3) is reported for those extracts that resulted in a consistent and noticeable kill zone compared to the diameter of the filter paper disc (6 mm). These extract-bacteria combinations were selected for use in the 96-well plate assays. For each extract-bacteria combination, a regression analysis was performed as follows . We first transformed concentration values by taking the negative value of the base-10 logarithm for each. This generated an x-axis whereby the smallest value (-2) denoted the strongest concentration (100%), the largest value (-0.49) denoted the weakest concentration (3.125%), and the slopes of the relationship were negative. Then, we regressed the transformed concentration value on proportion killed for each extract-bacteria combination to estimate the slope and y-intercept of the observed relationship. In addition to determining the strength and explanatory power of this linear relationship, we calculated a conservative estimate of the x-intercept. To do this, we determined the 95% confidence limits of the observed regression coefficient and then used the upper 95% limit as well as the observed y-intercept to calculate a predicted x-intercept. In other words, we used the steepest of likely slopes to predict the largest concentration at which the extract would stop killing bacteria. Once we determined this x-intercept, we back-transformed it to values of mg/mL extract. The smallest directly observable MIC in our experiment is 3.125 mg/mL; however, the strength of the observed linear relationships in our study gives us a fair amount of confidence in our conservatively predicted estimate as well.
Mean diameter of inhibition zones (mm) where bacterial growth was inhibited by plant extracts.
Mean inhibition zone diametera
E. coli (PI No.336)
S. typhimurium (PI No.381)
S. aureus (PI No.4651)
S. lactis (PI No.525)
Haudenosaunee medicinal plants
Plants with no known medicinal use by Haudenosaunee
Ampicillin (10 mg/mL)
Regression statistics, observed MIC (mg/mL) values and predicted MIC (mg/mL) values for all plant-extract and bacteria combinations with demonstrated inhibition in the disc diffusion assays.
Haudenosaunee medicinal plants
Plants with no known medicinal use by Haudenosaunee
We used the 95% confidence interval associated with the slope of each regression analyses to conservatively predict the MIC drawing on the linear trend observed in the serial dilution assay. Although by no means conclusive, this analysis gives insight into the relative efficacy of the extractions. The conservative nature of these estimates is illustrated by most of the S. aureus results where the predicted MIC is greater than the observed MIC. This analysis suggests that particular extract-bacteria combinations may result in MICs on the order of tens of μg/mL (H. matronalis stem - S. typhimurium; H. pilosella leaf - S. typhimurium; I. pandurata leaf - E. coli; R. multiflora leaf - E. coli) or hundreds of μg/mL (A. millefolium flower - S. typhimurium; I. pandurata leaf - S. typhimurium; R. multiflora flower - E. coli and S. typhimurium).
Traditional Haudenosaunee medicine involves a number of plant species native to NY. We selected a small subset of these plants and attempted to determine whether they exhibited antibacterial properties as measured through two different assays. In the discussion that follows, we first interpret these data with respect to our two main hypotheses and then turn to a discussion of those species that might indeed exhibit antibacterial properties. Before doing so, there are two important caveats of our study to highlight. First, although the medicinal uses of these plants were in the form of water-based poultices, decoctions, and infusions [6, 7], our extraction method most certainly does not capture the nuances of the actual preparations used. Second, we have no evidence that the bacteria used in this study (e.g., S. typhimurium) were indeed the causal agents underlying the symptoms associated with the use of these plants (e.g., infusion of smashed A. millefolium plants to treat diarrhea).
Our data are mixed with respect to the hypothesis that a correlation exists between the use of Haudenosaunee medicinal plants and antibacterial properties. Our analyses failed to find any evidence of antibacterial activity for three plants used in Haudenosaunee medicines (A. syriaca, M. neglecta, and R. acris) to treat broad-spectrum gastrointestinal ailments and as an antidiarrheal [6, 7]. However, extractions from four plants exhibited antibacterial properties as expected (A. millefolium, I. pandurata, H. pilosella, and S. canadensis), and it is interesting to note that neither of the two plant species used to treat non-bacterial symptoms (C. racemosa and L. digitatum), and only one of the native plant species without an ascribed medicinal use did so (S. virginica). We also hypothesized that if these plants had antibacterial properties, we would likely observe stronger effects in moderately virulent gram-negative and gram-positive bacteria (S. typhimurium and S. aureus) than in mostly avirluent gram-negative and gram-positive bacteria (E. coli and S. lactis). The data are in line with this prediction as 12/16 (75%) of the extracts causing inhibition zones did so against the moderately virulent bacteria. Taken together, these data suggest that although there is not complete concordance between ascribed use and antibacterial activity in the laboratory, the selection and use of these plants to treat disease was likely non-random.
Yarrow (A. millefolium) is recognized as a powerful medicinal plant in Haudenosaunee culture [6, 7], is widely distributed and has been used medicinally by a number of other cultures for thousands of years . In our study, A. millefolium showed antibacterial activity against S. typhimurium and S. aureus with predicted MICs on the order of 10 s of μg/mL or 10 s of mg/mL, respectively. A number of studies have investigated the antibacterial properties of this species [24–28] and found similar results to those presented here. One difference, however, is that two studies found that ether-hexane-methanol extracts of Yarrow caused inhibition zones against E. coli in disc diffusion assays [27, 28], whereas our study with aqueous extracts of flower, leaves, roots, and shoots and a separate study of essential oil and methanolic extracts  did not. These differing results could be due to the different extraction methods used or regional variation in the chemical constituents of the plants. It is well known that Yarrow represents a diverse, polyploid complex that is probably composed of dozens of species with varying biochemical compositions . The biochemical diversity of this complex has been fairly well described [30, 31], and it has been hypothesized that phenolic compounds such as flavonoids and phenolcarbonic acids may underlie the observed antimicrobial activity [27, 28, 31]. A number of other studies have found additional therapeutic properties including anti-inflammatory , antioxidant , and antinociceptive  properties. Moreover, there is growing evidence that both flavonoids and sesquiterpenoids have anti-proliferative effects against mouse P-388 leukemia cells  and cervix epithelial adenocarcinoma (HeLa), breast epithelial adenocarcinoma (MCF-7) and skin epidermoid carcinoma (A431) cells . Clearly, Yarrow holds great potential as a source of many new drugs.
Man-of-the-Earth (I. pandurata) is also recognized as a powerful medicinal plant in Haudenosaunee culture [6, 7], but is far less studied than Yarrow. In fact, we know of no previous investigations into the possible therapeutic properties of this species. Our results show that aqueous leaf extracts are strong inhibitors of all species of bacteria used in this study with predicted MICs of 1-10 s of μg/mL against E. coli and S. typhimurium and 100-1000 s of μg/mL against S. aureus and S. lactis. There are a few other investigations of other morning glory species in the literature showing antibacterial properties of I. batatas, I. murucoides and I. stans. In addition, there are studies demonstrating antifungal properties of undescribed Ipomoea species , antinociceptive properties of I. pes-caprae and I. cairica, anti-inflammatory and anti-spasmodic activity of I. imperati, central nervous system depressant activity of I. stans as well as cytotoxic activity , and antimycobacterial and cytotoxic activity of I. tyrianthina[44, 45].
Mouseear Hawkweed (H. pilosella) and Canada goldenrod (S. canadensis) were both used by Haudenosaunee peoples to treat gastrointestinal ailments and diarrhea [6, 7]. Our results show that mouseear hawkweed may weakly inhibit S. aureus (predicted MICs of 10 s of mg/mL) and more strongly inhibit S. typhimurium (predicted MIC of 1-10 s of μg/mL). These results are consistent with the results of a separate study that utilized methanol, dichloromethane, ethyl acetate, and dichloromethane:methanol (9:1) extractions , and with a study that utilized methanol and aqueous extracts ; however, our aqueous extractions were not effective against E. coli as in the other extractions of these two studies. We are aware of only two other investigations of this species, finding that flavonoids from H. pilosella have antioxidant activity [46, 48]. Canada goldenrod only inhibited S. aureus in our study at a relatively weak predicted MIC (1-10 s of mg/mL). Although we know of no other studies that have investigated the antimicrobial properties of this species, methanol extractions of root tissue show moderate antioxidant activity , and two studies have documented the antifungal properties of the essential oil of S. chilensis and the anti-inflammatory properties of ethanol extracts of S. chilensis.
It was somewhat surprising that Fire Pink (S. virginica) weakly inhibited the growth of S. aureus (predicted MIC of 10 s of mg/mL). The Silene complex is well known for phytoecdysteroids [52, 53], but this is the first report of possible antibacterial properties. Likewise, it was surprising that Dames Rocket (H. matronalis) was strongly effective against S. typhimurium (predicted MIC of 1-10 s of μg/mL) because we know of no other studies showing any therapeutic properties of this genus. There are a number of studies demonstrating the nutritional, anti-inflammatory, analgesic, and anti-oxidant properties of Multiflora Rose (R. multiflora) hips and other members of the genus [54, 55]. A study of wild rose hips in Canada found some evidence for weak anti-microbial activity against yeast and gram-positive bacteria . However, our results show that flower and leaf aqueous extracts are effective against gram-negative bacteria (E. coli and S. typhimurium) at predicted MICs on the order of 10 s of μg/mL.
Growing antibiotic resistance among human pathogens [57–59] and new data showing that antibiotic-resistant E. coli can protect antibiotic-sensitive S. typhimurium without gene transfer , emphasize the importance of finding new antibacterial molecules. Our data suggest that investigating traditional Haudenosaunee medicinal plants may yield promising new leads. The degree of concordance between traditional use and observed antibacterial properties suggest that there may be some truth to these remedies. In particular, our results suggest that A. millefolium, H. pilosella, I. pandurata, and S. canadensis warrant further study, as does the previously undocumented H. matronalis, especially in the context of S. typhimurium. Elucidating the mode of action behind these observed antibacterial properties, as well as exploring other pharmacological activities is currently underway in our lab.
We thank T Ackley, L Carey, D Leet, and C Twomey for their assistance in the field and laboratory. The authors are grateful to S Ignacimuthu and RE Robles-Zepeda for providing comments that greatly improved the quality and clarity of this work. We received support for this project through a Sherman-Fairchild Fellowship (RM), the Research Council at Colgate University (FMF), and the Department of Biology at Colgate University (FMF).
- Moerman DE: An analysis of the food plants and drug plants of native North America. Journal of Ethnopharmacology. 1996, 52: 1-22. 10.1016/0378-8741(96)01393-1.View ArticlePubMedGoogle Scholar
- Moerman DE: Native American Ethnobotany. 1998, Portland: Timber PressGoogle Scholar
- Moerman DE: The medicinal flora of native North America: an analysis. Journal of Ethnopharmacology. 1991, 31: 1-42. 10.1016/0378-8741(91)90141-Y.View ArticlePubMedGoogle Scholar
- Moerman DE, Estabrook GF: Native Americans' choice of species for medicinal use is dependent on plant family: confirmation with meta-significance analysis. Journal of Ethnopharmacology. 2003, 87: 51-59. 10.1016/S0378-8741(03)00105-3.View ArticlePubMedGoogle Scholar
- Lewis WH, Elvin-Lewis MPF: Medical botany: plants affecting human health. 2003, Hoboken: John Wiley and Sons, Inc, SecondGoogle Scholar
- Herrick JW: Iroquois Medical Botany. PhD thesis. 1977, State University of New York, Anthropology departmentGoogle Scholar
- Herrick JW: Iroquois Medical Botany. 1995, Syracuse: Syracuse University PressGoogle Scholar
- Arnason JT, Hebda R, Richard J, Johns T: Use of plants for food and medicine by native peoples of eastern Canada. Canadian Journal of Botany. 1981, 59: 2189-2325. 10.1139/b81-287.View ArticleGoogle Scholar
- McCutcheon AR, Ellis RM, Hancock REW, Towers GHN: Antibiotic screening of medicinal plants of the British Columbian native peoples. Journal of Ethnopharmacology. 1992, 37: 213-223. 10.1016/0378-8741(92)90036-Q.View ArticlePubMedGoogle Scholar
- McCutcheon AR, Ellis SM, Hancock REW, Towers GHN: Antifungal screening of medicinal plants of the British Columbian native peoples. Journal of Ethnopharmacology. 1994, 44: 157-169. 10.1016/0378-8741(94)01183-4.View ArticlePubMedGoogle Scholar
- McCutcheon AR, Roberts TE, Gibbons E, Ellis SM, Babiuk LA, Hancock REW, Towers GHN: Antiviral screening of British Columbian medicinal plants. Journal of Ethnopharmacology. 1995, 49: 101-110. 10.1016/0378-8741(95)90037-3.View ArticlePubMedGoogle Scholar
- Bergeron C, Marston A, Gauthier R, Hostettmann K: Screening of plants used by North American Indians for antifungal, bactericidal, larvicidal, and molluscicidal activities. International Journal of Pharmacognosy. 1996, 34: 233-242. 10.1076/phbi.126.96.36.19924.View ArticleGoogle Scholar
- McCutcheon AR, Stokes RW, Thorson LM, Ellis SM, Hancock REW, Towers GHN: Anti-mycobacterial screening of British Columbian medicinal plants. International Journal of Pharmacognosy. 1996, 35: 77-83. 10.1076/phbi.188.8.131.5284.View ArticleGoogle Scholar
- Jones NP, Arnason JT, Abou-Zaid M, Akpagana K, Sanchez-Vindas P, Smith ML: Antifungal activity of extracts from medicinal plants used by First Nations Peoples of eastern Canada. Journal of Ethnopharmacology. 2000, 73: 191-198. 10.1016/S0378-8741(00)00306-8.View ArticlePubMedGoogle Scholar
- Omar S, Lemonnier B, Jones N, Ficker C, Smith ML, Neema C, Towers GHN, Goel K, Arnason JT: Antimicrobial activity of extracts of eastern North American hardwood trees in relation to traditional medicines. Journal of Ethnopharmacology. 2000, 73: 161-170. 10.1016/S0378-8741(00)00294-4.View ArticlePubMedGoogle Scholar
- Webster D, Taschereau P, Belland RJ, Sand C, Rennie RP: Antifungal activity of medicinal plant extracts; preliminary screening studies. Journal of Ethnopharmacology. 2008, 115: 140-146. 10.1016/j.jep.2007.09.014.View ArticlePubMedGoogle Scholar
- Aguirre M, Collins MD: Lactic acid bacteria and human clinical infection. Journal of Applied Bacteriology. 1993, 75: 95-107.View ArticlePubMedGoogle Scholar
- Mofredj A, Bahloul H, Chanut C: Lactococcus lactis: an opportunistic bacterium?. Medecine et Maladies Infectieuses. 2007, 37: 200-207. 10.1016/j.medmal.2007.01.005.View ArticlePubMedGoogle Scholar
- Levinson W: Review of medical microbiology and immunology. 2008, New York: McGraw-Hill Medical, TenthGoogle Scholar
- Bauer AW, Kirby WMM, Sherris JC, Turck M: Antibiotic susceptibility testing by a standardized single disk method. American Journal of Clinical Pathology. 1996, 45: 493-496.Google Scholar
- Eloff JN: A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Medica. 1998, 64: 711-713. 10.1055/s-2006-957563.View ArticlePubMedGoogle Scholar
- Sokal RR, Rohlf FJ: Biometry: the principles and practice of statistics in biological research. 1995, New York: W.H. Freeman, ThirdGoogle Scholar
- Mitich LW: Intriguing world of weeds: Yarrow - the herb of Achilles. Weed Technology. 1990, 4: 451-453.Google Scholar
- Barel S, Segal R, Yashphe J: The antimicrobial activity of the essential oil from Achillea fragrantissima. Journal of Ethnopharmacology. 1991, 33: 187-191. 10.1016/0378-8741(91)90177-F.View ArticlePubMedGoogle Scholar
- Smith-Palmer A, Stewart J, Fyfe L: Antimicobial properties of plant essential oils and essences against 5 important food-borne pathogens. Letters in Applied Microbiology. 1998, 26: 118-122. 10.1046/j.1472-765X.1998.00303.x.View ArticlePubMedGoogle Scholar
- Candan F, Unlu M, Tepe B, Daferera D, Polissiou M, Sökmen A, Akpulat HS: Antioxidant and antimicrobial activity of the essential oil and methanol extracts of Achillea millefolium subsp. Millefolium Afan. (Asteraceae). Journal of Ethnopharmacology. 2003, 87: 215-220. 10.1016/S0378-8741(03)00149-1.View ArticlePubMedGoogle Scholar
- Stojanović G, Radulović N, Hashimoto T, Palić R: In vitro antimicrobial activity of extracts of four Achillea species: The composition of Achillea clavennae L. (Asteraceae) extract. Journal of Ethnopharmacology. 2005, 101: 185-190. 10.1016/j.jep.2005.04.026.View ArticlePubMedGoogle Scholar
- Tajik H, Jalali FSS, Sobhani A, Shahbazi Y, Zadeh MS: In vitro assessment of antimicrobial efficacy of alcoholic extract of Achillea millefolium in comparison with penicillin derivatives. Journal of Animal and Veterinary Advances. 2008, 7: 508-511.Google Scholar
- Guo YP, Saukel J, Mittermayr R, Ehrendorfer F: AFLP analyses demonstrate genetic divergence, hybridization, and multiple polyploidization in the evolution of Achillea (Asteraceae-Anthemideae). New Phytologist. 2005, 166: 273-290. 10.1111/j.1469-8137.2005.01315.x.View ArticlePubMedGoogle Scholar
- Si XT, Zhang ML, Shi QW, Kiyota H: Chemical constituents of the plants in the genus Achillea. Chemistry and Biodiversity. 2006, 3: 1163-1180. 10.1002/cbdv.200690119.View ArticlePubMedGoogle Scholar
- Benedek B, Gjoncaj N, Saukel J, Kopp B: Distribution of the phenolic compounds in Middleeuropean taxa of the Achillea millefolium L. aggregate. Chemistry and Biodiversity. 2007, 4: 849-857. 10.1002/cbdv.200790072.View ArticlePubMedGoogle Scholar
- Tunón H, Olavsdotter C, Bohlin L: Evaluation of anti-inflammatory activity of some Swedish medicinal plants: Inhibition of prostaglandin biosynthesis and PAF-induced exocytosis. Journal of Ethnopharmacology. 1995, 48: 61-76. 10.1016/0378-8741(95)01285-L.View ArticlePubMedGoogle Scholar
- Pires JM, Mendes FR, Negri G, Duarte-Almeida JM, Carlini EA: Antinociceptive peripheral effect of Achillea millefolium L. and Artemisia vulgaris L.: Both plants known popularly by brand names of analgesic drugs. Phytotherapy Research. 2009, 23: 212-219. 10.1002/ptr.2589.View ArticlePubMedGoogle Scholar
- Tozyo T, Yoshimura Y, Sakurai K, Uchida N, Takeda Y, Nakai H, Ishii H: Novel antitumor sesquiterpenoids in Achillea millefolium. Chemical and Pharmaceutical Bulletin. 1994, 42: 1096-1100.View ArticlePubMedGoogle Scholar
- Csupor-Löffler B, Hajdú Z, Zupkó I, Réthy B, Falkay G, Forgo P, Hohmann J: Antiproliferative effect of flavonoids and sesquiterpenoids from Achillea millefolium s.l. on cultured human tumour cell lines. Phytotherapy Research. 2009, 23: 672-676. 10.1002/ptr.2697.View ArticlePubMedGoogle Scholar
- Islarn S: Antimicrobial activities of Ipomoea batatas (L.) leaf. Journal of Food, Agriculture, and Environment. 2008, 6: 14-17.Google Scholar
- Chérigo L, Pereda-Miranda R, Fragoso-Serrano M, Jacobo-Herrera N, Kaatz GW, Gibbons S: Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides. Journal of Natural Products. 2008, 71: 1037-1045. 10.1021/np800148w.View ArticlePubMedGoogle Scholar
- Reynolds WF, Yu M, Enriquez RG, Gonzalez H, Leon I, Magos G, Villareal ML: Isolation and characterization of cytotoxic and antibacterial tetrasaccharide glycosides from Ipomoea stans. Journal of Natural Products. 1995, 58: 1730-1734. 10.1021/np50125a014.View ArticlePubMedGoogle Scholar
- Goun E, Cunningham G, Chu D, Nguyen C, Miles D: Antibacterial and antifungal activity of Indonesian ethnomedical plants. Fitoterapia. 2003, 76: 592-596. 10.1016/S0367-326X(03)00117-5.View ArticleGoogle Scholar
- de Souza MM, Madeira A, Berti C, Krogh R, Yunes RA, Cechinel-Filho V: Antinociceptive properties of the methanolic extract obtained from Ipomoea pes-caprae (L.) R. Br. Journal of Ethnopharmacology. 2000, 69: 85-90. 10.1016/S0378-8741(99)00142-7.View ArticlePubMedGoogle Scholar
- Ferreira AA, Amaral FA, Duarte IDG, Oliveira PM, Alves RB, Silveira D, Azevedo AO, Raslan DS, Castro MSA: Antinociceptive effect from Ipomoea cairica extract. Journal of Ethnopharmacology. 2006, 105: 148-153. 10.1016/j.jep.2005.10.012.View ArticlePubMedGoogle Scholar
- Paula ACB, Hayashi LSS, Freitas JC: Anti-inflammatory and antispasmodic activity of Ipomoea imperati (Vahl) Griseb (Convolvulaceae). Brazilian Journal of Medical and Biological Research. 2003, 36: 105-112. 10.1590/S0100-879X2003000100014.View ArticlePubMedGoogle Scholar
- Herrera-Ruiz M, Gutiérrez C, Jiménez-Ferrer JE, Tortoriello J, Mirón G, León I: Central nervous system depressant activity of an ethyl acetate extract from Ipomoea stans roots. Journal of Ethnopharmacology. 2007, 112: 243-247. 10.1016/j.jep.2007.03.004.View ArticlePubMedGoogle Scholar
- León-Rivera I, Mirón-López G, Molina-Salinas GM, Herrera-Ruiz M, Estrada-Soto S, del Carmen Gutiérrez M, Alonso-Cortes D, Navarrete-Vázquez G, Ríos MY, Said-Fernández S: Tyrianthinic acids from Ipomoea tyrianthina and their antimycobacterial activity, cytotoxicity, and effects on the central nervous system. Journal of Natural Products. 2008, 71: 1686-1691. 10.1021/np800266a.View ArticlePubMedGoogle Scholar
- León-Rivera I, Mirón-López G, Estrada-Soto S, Aguirre-Crespo F, del Carmen Gutiérrez M, Molina-Salinas GM, Hurtado G, Navarrete-Vázquez G, Montiel E: Glycopipid ester-type heterodimers from Ipomoea tyrianthina and their pharmacological activity. Bioorganic and Medicinal Chemistry Letters. 2009, 19: 4652-4656. 10.1016/j.bmcl.2009.06.087.View ArticlePubMedGoogle Scholar
- Stanojević L, Stanojević MZ, Nikolić VD, Nikolić LB: Anti-oxidative and antimicrobial activities of Hieracium pilosella L. extracts. Journal of the Serbian Chemical Society. 2008, 73: 531-540. 10.2298/JSC0805531S.View ArticleGoogle Scholar
- Barbour EK, Al Sharif M, Sagherian VK, Habre AN, Talhouk RS, Tahouk SN: Screening of selected indigenous plants of Lebanon for antimicrobial activity. Journal of Ethnopharmacology. 2004, 93: 1-7. 10.1016/j.jep.2004.02.027.View ArticlePubMedGoogle Scholar
- Stanojević L, Stanojević MZ, Nikolić V, Nikolić L, Ristić D, Canadanovic-Brunet J, Tumbas V: Antioxidant activity and total phenolic and glavonoid contents of Hieracium pilosella L. extracts. Sensors. 2009, 9: 5702-5714. 10.3390/s90705702.View ArticlePubMedPubMed CentralGoogle Scholar
- McCune LM, Johns T: Antioxidant activity in medicinal plants associated with the symptoms of diabetes mellitus used by the Indigenous Peoples of the North American boreal forest. Journal of Ethnopharmacology. 2002, 82: 197-205. 10.1016/S0378-8741(02)00180-0.View ArticlePubMedGoogle Scholar
- Vila R, Mundina M, Tomi F, Furlán R, Zacchino S, Casanova J, Cañigueral S: Composition and antifungal activity of the essential oil of Solidago chilensis. Planta Medica. 2002, 68: 167-167. 10.1055/s-2002-20253.View ArticleGoogle Scholar
- Tamura EK, Jimenez RS, Waismam K, Gobbo-Neto L, Lopes NP, Malpezzi-Marinho EAL, Marinho EAV, Farsky SHP: Inhibitory effects of Solidago chilensis Meyen hydroalcoholic extract on acute inflammation. Journal of Ethnopharmacology. 2009, 122: 478-485. 10.1016/j.jep.2009.01.029.View ArticlePubMedGoogle Scholar
- The Ecdysone Handbook. [http://ecdybase.org/]
- Tóth N, Simon A, Tóth G, Kele Z, Hunyadi A, Báthori M: 26-hydroxylated ecdysteroids from Silene viridiflora. Journal of Natural Products. 2008, 71: 1461-1463. 10.1021/np800139q.View ArticlePubMedGoogle Scholar
- Zhang GQ, Huang XD, Wang H, Leung AK-N, Chan CL, Fong DWF, Yu ZL: Anti-inflammatory and analgesic effects of the ethanol extract of Rosa multiflora Thunb. hips. Journal of Ethnopharmacology. 2008, 118: 290-294. 10.1016/j.jep.2008.04.014.View ArticlePubMedGoogle Scholar
- van der Westhuizen FH, van Rensburg CSJ, Rautenbach GS, Marnewick JL, Loots DT, Huysamen C, Louw R, Pretorius PJ, Erasmus E: In vitro antioxidant, antimutagenic, and genoprotective activity of Rosa roxburghii fruit extract. Phytotherapy Research. 2008, 22: 376-383. 10.1002/ptr.2330.View ArticlePubMedGoogle Scholar
- Yi O, Jovel EM, Towers GHN, Wahbe TR, Cho D: Antioxidant and antimicrobial activities of native Rosa sp. From British Columbia, Canada. International Journal of Food Sciences and Nutrition. 2007, 58: 178-189. 10.1080/09637480601121318.View ArticlePubMedGoogle Scholar
- Rice LB: Emergence of vancomycin-resistant enterococci. Emerging Infectious Diseases. 2001, 7: 183-187. 10.3201/eid0702.010205.View ArticlePubMedPubMed CentralGoogle Scholar
- Sack RB, Khan EH: Antimicrobial resistance in organisms causing diarrheal disease. Clinical Infectious Diseases. 1997, 24 (Suppl 1): S102-S105.View ArticlePubMedGoogle Scholar
- Westh H, Zinn CS, Rosdahl VT, Sarisa Study Group: An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries. Microbial Drug Resistance. 2004, 10: 169-176. 10.1089/1076629041310019.View ArticlePubMedGoogle Scholar
- Perlin MH, Clark DR, McKenzie C, Patel H, Jackson N, Kormanik C, Powell C, Bajorek A, Myers DA, Dugatkin LA, Atlas RM: Protection of Salmonella by ampicillin-resistant Escherichia coli in the presence of otherwise lethal drug concentrations. Proceedings of the Royal Society of London Series B. 2009, 276: 3759-3768. 10.1098/rspb.2009.0997.View ArticlePubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/10/64/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.